Table of Contents
Chapter I . Executive Summary
- Scope
- Personalized Medicine Market Segmentation
- The Broader Personalized Medicine Industry Landscape: Selected Therapies,
Biomarkers, and Indications
- Personalized Medicine: Quantitative Market Metrics (market size, product
class projected revenues, growth rate)
Chapter II . Personalized Medicine: Technology Landscape
- Definition of Personalized Medicine
- Growth of Personalized Medicine
- Examples of Personalized Medicine in Clinical Practice together with
Details of Mechanism of Action in vivo
- Companion Diagnostics drive Companion Therapeutics Sales
- The US FDA is a Driver for Personalized Medicine Market Adoption
- Emerging Trends and Themes in Personalized Medicine
Chapter III . Cancer Personalized Medicine Market Landscape
- [a]. Coupled Diagnostics/Therapeutics for Cancer - The Market Landscape of
the Major Commercial Products
- [b]. Predictors of Clinical Outcome in Breast Cancer Commercialized
Multigene Predictors of Clinical Outcome for Breast Cancer
- [c]. Personalized Medicine in Other Cancers and the Landscape of the
Emerging Cancer Personalized Medicine Space FLT3 for Acute Myeloid Leukemia
(AML)
- [d]. Personalized Medicine in Oral Anticoagulant (warfarin) Therapy
- [e]. Cancer Personalized Medicine Worldwide Primary Market Survey Data
- Respondent Pool Characterization
- Segmentation based on Type of Areas in Personalized Medicine
- Cancer Personalized Medicine Market Segmentation
- Segmentation of the Broader Personalized Medicine Marketplace by
- Therapeutic/Disease Areas Addressed Currently
- Segmentation of the Cancer Personalized Medicine Space by Types of Cancer
- Focused upon Currently
- Market Segmentation by Types of Biomarkers Studied Currently
- Segmentation of the Personalized Medicine Marketplace by Study of
microRNAs, Epigenetic Changes
- Market Penetrance of Technologies Currently Utilized in Personalized
Medicine
- Current Penetrance of Various Diagnostic Platforms into Personalized
Medicine
- Personalized Medicine Tests: Drivers and Challenges in Market Adoption
Chapter IV. MicroRNA Diagnostics and Therapeutics: Technology and Market Landscape
- Current Status of the MicroRNA Marketplace
- MicroRNA Dysregulation is Associated/Linked with Disease Processes
(primarily cancer)
- MicroRNA Cancer Mapping
- MicroRNAs that are Associated with Human Cancers
- MicroRNAs Associated with Diseases Other than Cancer
- Developmental Pathways Regulated by MicroRNAs
- MicroRNAs Regulating Cancer-related Genes
- MicroRNA Polymorphisms
- Deployment of MicroRNAs as Diagnostics and Therapeutics: Market Analysis
- Emerging Market Participants: Selected MicroRNA Diagnostics and
- Therapeutics-focused Companies (Company Profiles: Areas of Focus, Business
Models)
- Industry Update: MicroRNA Therapeutics in Development
- Industry Update: Milestones of Note in the MicroRNA Diagnostics and
Therapeutics Space
Appendix I. Research Methodology
Appendix II. Regulatory Guidelines in Personalized Medicine
Appendix III. Drug Metabolism Drives Efficacy and Toxicity
|
Related Report
|
View Cart
